RxDoctor Payments Data

Charles Perl

Family Medicine · West Palm Beach, FLNPI 1659334571

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 25.6% of the total. Reporting peaked in 2021 at $590 and has fallen 87.4% since, to $74 in 2022.

$1,377in general payments, 2019–2025

Across 89 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$352
  • Novo Nordisk$322
  • Pfizer$149
  • AstraZeneca$96
  • Biohaven Pharmaceuticals, Inc.$73
  • Optinose US, Inc.$58
  • plus $326 from 13 others

What the payments were for

  • Food & beverage$1,377100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,377 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida →

Other family medicine in West Palm Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →